IX(IX)
IX
$40.25—Stale · unknown old
NYSE • Last print unknown ago
$40.25—Stale · unknown old
No analyst ratings available
No analyst price targets available for IX
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $3.64T | $3.73T | $3.93T | $4.09T | $4.23T |
| Low | $3.54T | $3.63T | $3.82T | $3.98T | $4.12T |
| High | $3.74T | $3.83T | $4.04T | $4.20T | $4.35T |
| EBITDA Avg | $1.75T | $1.22T | $1.29T | $1.34T | $1.42T |
| Low | $1.71T | $1.21T | $1.26T | $1.30T | $1.39T |
| High | $1.79T | $1.22T | $1.32T | $1.37T | $1.46T |
| EBIT Avg | $1.34T | $814.15B | $891.00B | $938.81B | $1.02T |
| Low | $1.30T | $811.42B | $859.92B | $906.06B | $986.96B |
| High | $1.37T | $819.61B | $923.48B | $973.04B | $1.06T |
| Net Income Avg | $930.62B | $566.59B | $620.07B | $653.34B | $711.67B |
| Low | $904.77B | $564.68B | $598.44B | $630.55B | $686.85B |
| High | $956.47B | $570.39B | $642.67B | $677.16B | $737.62B |
| EPS Avg | $831.02 | $505.95 | $553.70 | $583.42 | $635.50 |
| Low | $807.94 | $504.25 | $534.39 | $563.07 | $613.34 |
| High | $854.11 | $509.34 | $573.89 | $604.69 | $658.67 |
| Analysts (Rev / EPS) | 2 / 1 | 3 / 1 | 1 / 1 | 2 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $1.01T | $962.86B | $763.57B | $839.20B | $857.82B | $876.44B | $895.07B | $975.36B |
| Low | $1.01T | $962.86B | $763.57B | $839.20B | $857.82B | $876.44B | $895.07B | $975.36B |
| High | $1.01T | $962.86B | $763.57B | $839.20B | $857.82B | $876.44B | $895.07B | $975.36B |
| EBITDA Avg | $494.62B | $338.85B | $208.25B | $260.84B | $263.68B | $266.65B | $270.62B | $285.10B |
| Low | $494.62B | $338.85B | $208.25B | $260.84B | $263.68B | $266.65B | $270.62B | $285.10B |
| High | $494.62B | $338.85B | $208.25B | $260.84B | $263.68B | $266.65B | $270.62B | $285.10B |
| EBIT Avg | $393.56B | $238.18B | $108.91B | $162.40B | $166.00B | $169.60B | $174.07B | $188.65B |
| Low | $393.56B | $238.18B | $108.91B | $162.40B | $166.00B | $169.60B | $174.07B | $188.65B |
| High | $393.56B | $238.18B | $108.91B | $162.40B | $166.00B | $169.60B | $174.07B | $188.65B |
| Net Income Avg | $273.89B | $165.75B | $75.79B | $113.01B | $115.52B | $118.03B | $121.14B | $131.29B |
| Low | $273.89B | $165.75B | $75.79B | $113.01B | $115.52B | $118.03B | $121.14B | $131.29B |
| High | $273.89B | $165.75B | $75.79B | $113.01B | $115.52B | $118.03B | $121.14B | $131.29B |
| EPS Avg | $249.24 | $150.84 | $68.97 | $102.84 | $105.13 | $107.41 | $110.24 | $119.47 |
| Low | $249.24 | $150.84 | $68.97 | $102.84 | $105.13 | $107.41 | $110.24 | $119.47 |
| High | $249.24 | $150.84 | $68.97 | $102.84 | $105.13 | $107.41 | $110.24 | $119.47 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |